Information Request Email, November 30, 2012 - RIXUBIS


From:                    Thompson, Edward

Sent:                      Friday, November 30, 2012 2:26 PM

To:                         'Smyth, Kevin R'

Cc:                         Ovanesov, Mikhail V.; Drews, Roman T; Campbell, Karen M

Subject:                 Request for Drug Product Conformance Lot Samples to Original BL 125446/0

 

Attachments:         Licensing Sample template letter doc (2).doc; _Lot Release Protocol Template Basic(newer) pdf.pdf

Dear Mr. Smyth:

 

We are reviewing your August 28, 2012 biologics license application (BLA) for Coagulation Factor IX (Recombinant). We are requesting additional information to continue our review:

 

1. Please submit b(4) samples each of the drug product conformance lots b(4)------------------------------------------------ to the following address:

 

Karen Campbell

Regulatory Coordinator (DBSQC)

OCBQ/CBER/FDA

Building B - Room 2410

5516 Nicholson Lane

Kensington, MD 20895

       

Please contact Karen via email at karen.campbell@fda.hhs.gov or via telephone at 301-594-6255 prior to sample submission to alert CBER that the samples are being sent. The samples should be accompanied by a Letter for Licensing Sample Submission, and their respective Lot Release Protocols. Templates of the Letter and Lot Release Protocol are enclosed for your reference. 

  

The review of this submission is on-going and issues may be added, expanded upon, or modified as we continue to review this submission.

 

Please submit your responses to this information request by December 15, 2012 referencing the date of this request. Please email me when you have shipped these samples. If you anticipate you will not be able to respond by this date, please contact the Agency immediately so a new response date can be identified.

 

The action due date for this file is June 30, 2013.

 

If you have any questions, please contact me.

 

Sincerely,

Edward M. Thompson

Regulatory Project Manager

HFM-380 FDA/CBER

Office of Blood Research and Review

Division of Blood Applications

301-827-9167, Fax 301-827-2857

email: edward.thompson@fda.hhs.gov

1401 Rockville Pike, Room 554N

Rockville, MD 20852-1448